category,datetime,headline,id,image,related,source,summary,url
company,1768257903,Johnson & Johnson (JNJ) Beats Stock Market Upswing: What Investors Need to Know,138083196,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"Johnson & Johnson (JNJ) closed the most recent trading day at $209.72, moving +2.61% from the previous trading session.",https://finnhub.io/api/news?id=5cc719165e2d6d2275ecd66af89bfa856a8e419b90530bb2d4e50b3205db9588
company,1768240904,"What $6,500 a Month Really Looks Like in Retirement at 67",138078048,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"Retiring at 67 with $6,500 in monthly income places you solidly in middle-class territory, but the financial reality behind that figure is more nuanced than it appears. With average Social Security benefits at $2,017 per month in 2026, a retiree targeting $6,500 needs to generate roughly $4,483 monthly—or $53,796 annually—from personal savings and investments. The ... What $6,500 a Month Really Looks Like in Retirement at 67",https://finnhub.io/api/news?id=6893e956b6faae41cdb1adaa3ed4f00fff9f2f71cae9fb0f95d173a221eb60ef
company,1768240167,How Much Monthly Income Does a $2 Million Portfolio Produce at Age 60?,138078053,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"At 60 years old with $2 million saved, you can safely say that you are in a good position that most people will never reach. At this point, the question in your mind should shift from whether you have enough to retire to how much income you can generate from a $2 million portfolio to ... How Much Monthly Income Does a $2 Million Portfolio Produce at Age 60?",https://finnhub.io/api/news?id=fedc778d52b52655d54a7391294fa295505d3844360c695d47304ffb582809d7
company,1768239621,Gilead Sciences: From All-Time Highs To Higher Highs,138078945,https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1958960897/image_1958960897.jpg?io=getty-c-w1536,JNJ,SeekingAlpha,"Gileadâs Yeztugo launch, rising margins, and CAR-T pipeline progress (anito-cel, KITE-753/363) support a 2026 bull caseâread the outlook now.",https://finnhub.io/api/news?id=98acfd77875786e8d559978005ee16a3b1a789ed2a121272d2d0fcf0342e906a
company,1768235880,‘Biotech Super Bowl’ Lands With a Thud. Stocks Slide on Lack of Deal News.,138076408,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"Monday is the first day of  J.P. Morgan’s  annual healthcare investor conference, which draws thousands of investors, analysts, and executives to San Francisco each year.  There is ample precedent: Last year,  Johnson & Johnson  announced a $14.6 billion deal to acquire Intra-Cellular Therapeutics on the first day of the gathering.  The Wall Street Journal reported last week that Merck was in talks to buy the biotech Revolution Medicines for roughly $30 billion, but as of late morning, no such agreement had been announced.",https://finnhub.io/api/news?id=a8e42fa0176125b6d61a239d1fc7e9d3ac654534ef8fe6ce6ee1a22fdfcc0ed8
company,1768233180,"Walmart, Johnson & Johnson share gains lead Dow's 125-point climb",138124047,,JNJ,MarketWatch,"Walmart, Johnson & Johnson share gains lead Dow's 125-point climb",https://finnhub.io/api/news?id=a36f19ec3e45c3e14d06debf2f5f39294706f7f02e833151f6036ca85cda0243
company,1768226762,Johnson & Johnson (JNJ) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript,138077188,https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png,JNJ,SeekingAlpha,"Johnson & Johnson (JNJ) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 11:15 AM ESTCompany ParticipantsJoaquin Duato - CEO &...",https://finnhub.io/api/news?id=0f19fc8c16752d237337938a2991dbf249d63a5cb0b76f3db3f1a91e25b6a07e
company,1768226400,Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System,138072323,https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png,JNJ,Yahoo,"Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System Distalmotion, the global MedTech company empowering access to robotic surgery in outpatient sites of care, today announced a strategic investment from Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation – JJDC, Inc (“JJDC”). This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capit",https://finnhub.io/api/news?id=656167c7929d90e4f0f59c76b61821b15f0ec52dbf6f6db05ee116c4160a274d
